{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:48:15Z","timestamp":1740134895203,"version":"3.37.3"},"reference-count":10,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1,27]]},"DOI":"10.1182\/blood.2021014133","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T16:33:36Z","timestamp":1643301216000},"page":"475-476","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["Metabolic path toward TCF3 inactivation in Burkitt lymphoma"],"prefix":"10.1182","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4789-967X","authenticated-orcid":false,"given":"Ulf","family":"Klein","sequence":"first","affiliation":[{"name":"University of Leeds"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2022012716332005600_B1","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2021012081","article-title":"SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma","author":"Wilke","year":"2022","journal-title":"Blood."},{"issue":"15","key":"2022012716332005600_B2","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMra0807082","article-title":"Aggressive lymphomas","volume":"362","author":"Lenz","year":"2010","journal-title":"N Engl J Med."},{"issue":"26","key":"2022012716332005600_B3","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1182\/blood-2014-03-563627","article-title":"Improved outcome of adult Burkitt lymphoma\/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial","volume":"124","author":"Hoelzer","year":"2014","journal-title":"Blood."},{"issue":"24","key":"2022012716332005600_B4","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1182\/blood-2012-12-475558","article-title":"Trends in survival of patients with Burkitt lymphoma\/leukemia in the USA: an analysis of 3691 cases","volume":"121","author":"Costa","year":"2013","journal-title":"Blood."},{"issue":"3","key":"2022012716332005600_B5","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nri3814","article-title":"Germinal centres and B cell lymphomagenesis","volume":"15","author":"Basso","year":"2015","journal-title":"Nat Rev Immunol."},{"issue":"7418","key":"2022012716332005600_B6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","article-title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics","volume":"490","author":"Schmitz","year":"2012","journal-title":"Nature."},{"issue":"19","key":"2022012716332005600_B7","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1182\/blood.2019001880","article-title":"The whole-genome landscape of Burkitt lymphoma subtypes","volume":"134","author":"Panea","year":"2019","journal-title":"Blood."},{"issue":"2","key":"2022012716332005600_B8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccr.2012.06.012","article-title":"Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis","volume":"22","author":"Sander","year":"2012","journal-title":"Cancer Cell."},{"issue":"5","key":"2022012716332005600_B9","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1038\/s41596-021-00506-4","article-title":"Genetic manipulation and immortalized culture of ex vivo primary human germinal center B cells","volume":"16","author":"Caeser","year":"2021","journal-title":"Nat Protoc."},{"issue":"6","key":"2022012716332005600_B10","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s43018-020-0080-0","article-title":"The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing","volume":"1","author":"Parsa","year":"2020","journal-title":"Nat Can."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/139\/4\/475\/1864200\/bloodbld2021014133c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/139\/4\/475\/1864200\/bloodbld2021014133c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T16:33:44Z","timestamp":1643301224000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/139\/4\/475\/483581\/Metabolic-path-toward-TCF3-inactivation-in-Burkitt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,27]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,1,27]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2021014133","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"type":"print","value":"0006-4971"},{"type":"electronic","value":"1528-0020"}],"subject":[],"published":{"date-parts":[[2022,1,27]]}}}